Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06173999
PHASE1/PHASE2
A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
View on ClinicalTrials.gov
Summary
The study is being conducted to evaluate the safety and efficacy of SHR2554 with CHOP/CHOEP in treatment- naïve peripheral T-cell lymphoma.
Official title: A Phase Ib/II, Open-label, Multi-center Study of SHR2554 With CHOP/CHOEP in Treatment-naïve Patients With Peripheral T-cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-12-22
Completion Date
2025-12-31
Last Updated
2024-05-14
Healthy Volunteers
No
Conditions
Interventions
DRUG
SHR2554/CHOP
SHR2554 with CHOP
DRUG
SHR2554/CHOEP
SHR2554 with CHOEP
Locations (1)
Beijing Cancer Hospital
Beijing, Beijing Municipality, China